Bayer Cropscience Limited
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance… Read more
Bayer Cropscience Limited (BAYERCROP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.011x
Based on the latest financial reports, Bayer Cropscience Limited (BAYERCROP) has a cash flow conversion efficiency ratio of -0.011x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹-349.00 Million) by net assets (₹31.23 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bayer Cropscience Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Bayer Cropscience Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bayer Cropscience Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bayer Cropscience Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Semitronix Corp. A
SHE:301095
|
N/A |
|
COFCO Capital Holdings Co Ltd
SHE:002423
|
0.249x |
|
Redde Northgate PLC
F:21W
|
0.021x |
|
Kunshan Kersen Science & Tech
SHG:603626
|
-0.012x |
|
Faw Car Co Ltd
SHE:000800
|
-0.154x |
|
MFA Financial Inc
NYSE:MFA
|
0.008x |
|
Teladoc Inc
NYSE:TDOC
|
0.071x |
|
T1 Energy Inc.
NYSE:TE
|
0.410x |
Annual Cash Flow Conversion Efficiency for Bayer Cropscience Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Bayer Cropscience Limited from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹28.50 Billion | ₹3.00 Billion | 0.105x | -68.46% |
| 2024-03-31 | ₹28.49 Billion | ₹9.52 Billion | 0.334x | +48.65% |
| 2023-03-31 | ₹27.12 Billion | ₹6.09 Billion | 0.225x | +163.16% |
| 2022-03-31 | ₹25.24 Billion | ₹2.15 Billion | 0.085x | -68.29% |
| 2021-03-31 | ₹25.50 Billion | ₹6.87 Billion | 0.269x | +4.02% |
| 2020-03-31 | ₹25.73 Billion | ₹6.66 Billion | 0.259x | +21.34% |
| 2019-03-31 | ₹18.83 Billion | ₹4.02 Billion | 0.213x | +212.50% |
| 2018-03-31 | ₹17.78 Billion | ₹1.21 Billion | 0.068x | -10.74% |
| 2017-03-31 | ₹20.57 Billion | ₹1.57 Billion | 0.076x | -31.62% |
| 2016-03-31 | ₹17.56 Billion | ₹1.96 Billion | 0.112x | +13.46% |
| 2015-03-31 | ₹20.33 Billion | ₹2.00 Billion | 0.099x | -38.99% |
| 2014-03-31 | ₹17.42 Billion | ₹2.81 Billion | 0.162x | +125.62% |
| 2013-03-31 | ₹19.31 Billion | ₹1.38 Billion | 0.072x | -46.80% |
| 2012-03-31 | ₹7.93 Billion | ₹1.07 Billion | 0.135x | -27.10% |
| 2011-03-31 | ₹6.73 Billion | ₹1.24 Billion | 0.185x | +25.50% |
| 2010-03-31 | ₹5.60 Billion | ₹823.59 Million | 0.147x | +91.64% |
| 2009-03-31 | ₹4.51 Billion | ₹346.20 Million | 0.077x | -79.80% |
| 2008-03-31 | ₹3.69 Billion | ₹1.40 Billion | 0.380x | +225.60% |
| 2007-03-31 | ₹3.31 Billion | ₹386.78 Million | 0.117x | +5.76% |
| 2006-03-31 | ₹3.31 Billion | ₹365.71 Million | 0.110x | -81.78% |
| 2005-03-31 | ₹2.58 Billion | ₹1.57 Billion | 0.606x | +107.93% |
| 2004-03-31 | ₹2.42 Billion | ₹704.91 Million | 0.291x | -- |